Uses of agonists and antagonists to modulate activity of TNF-related molecules

Details for Australian Patent Application No. 2006201471 (hide)

Owner Genentech, Inc.

Inventors Dodge, Kelly H; Marsters, Scot A; Yan, Minhong; Grewal, Iqbal; Ashkenazi, Avi J; Kim, Kyung Jin; Pitti, Robert M

Agent Griffith Hack

Pub. Number AU-B-2006201471

Parent 20485

Filing date 7 April 2006

Wipo publication date 4 May 2006

Acceptance publication date 23 July 2009

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

C07K 14/525 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

27 April 2006 Complete Application Filed

4 May 2006 Application Open to Public Inspection

  Published as AU-B-2006201471

23 July 2009 Application Accepted

  Published as AU-B-2006201471

19 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006201472-Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them

2006201470-Rotatable chuck